300 related articles for article (PubMed ID: 37374082)
1. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy.
Papaporfyriou A; Bartziokas K; Gompelmann D; Idzko M; Fouka E; Zaneli S; Bakakos P; Loukides S; Papaioannou AI
Life (Basel); 2023 May; 13(6):. PubMed ID: 37374082
[TBL] [Abstract][Full Text] [Related]
2. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review.
Balbirsingh V; Mohammed AS; Turner AM; Newnham M
Thorax; 2022 Jun; ():. PubMed ID: 35772939
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
5. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
6. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.
Müllerová H; Marshall J; de Nigris E; Varghese P; Pooley N; Embleton N; Nordon C; Marjenberg Z
Ther Adv Respir Dis; 2022; 16():17534666221113647. PubMed ID: 35894441
[TBL] [Abstract][Full Text] [Related]
7. Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases.
Deshmukh K; Khanna A
Tuberc Respir Dis (Seoul); 2021 Jan; 84(1):35-45. PubMed ID: 33045814
[TBL] [Abstract][Full Text] [Related]
8. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
10. Recent updates in chronic obstructive pulmonary disease.
Garvey C
Postgrad Med; 2016; 128(2):231-8. PubMed ID: 26560514
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?
Franssen FM; Rochester CL
Eur Respir Rev; 2014 Mar; 23(131):131-41. PubMed ID: 24591670
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors for chronic obstructive pulmonary disease.
Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
Chong J; Karner C; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review.
Santos NCD; Miravitlles M; Camelier AA; Almeida VDC; Maciel RRBT; Camelier FWR
Tuberc Respir Dis (Seoul); 2022 Jul; 85(3):205-220. PubMed ID: 35618259
[TBL] [Abstract][Full Text] [Related]
15. Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP.
Ge H; Liu X; Gu W; Feng X; Zhang F; Han F; Qian Y; Jin X; Gao B; Yu L; Bao H; Zhou M; Li S; Jie Z; Wang J; Chen Z; Hang J; Zhang J; Zhu H
J Inflamm Res; 2021; 14():3335-3348. PubMed ID: 34290518
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial.
Wise RA; Chapman KR; Scirica BM; Daoud SZ; Lythgoe D; Garcia-Gil E
Int J Chron Obstruct Pulmon Dis; 2021; 16():689-699. PubMed ID: 33776428
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
18. Statins versus placebo for people with chronic obstructive pulmonary disease.
Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].
Ambatiello LG; Chazova IE
Ter Arkh; 2020 Apr; 92(3):78-83. PubMed ID: 32598797
[TBL] [Abstract][Full Text] [Related]
20. [Chinese expert consensus on the management of cardiovascular comorbidities in patients with chronic obstructive pulmonary disease].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1180-1191. PubMed ID: 36480848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
